The 2020 COVID-19 vaccine is approaching reality: what we know about today’s top candidates

As the end of 2020 approaches, the COVID-19 vaccine has not yet been approved in the United States. However, this may change in the coming weeks.There are two candidates that you are most likely to receive first Approved by the Food and Drug Administration And Arrived for some people before 2021..

Not only that, but in clinical trials about two 95% valid For prevention of COVID-19 infection. This claim means that more than 9 out of 10 people vaccinated with these vaccines are unlikely to be infected with COVID-19, even if exposed. SARS-CoV-2A virus that causes illness after being inoculated.

US pharmaceutical giant Pfizer Vaccine showing 95% efficacy In the tests conducted To 43,538 people There are no serious safety concerns in the six countries.U.S. biotechnology company Moderna released its vaccine last week Almost 95% effective It is also relatively safe in trials involving more than 30,000 people. Another vaccine under development by the University of Oxford and the biotechnology company AstraZeneca is on average 70.4% effective. Oxford University announced on Monday.. Each vaccine requires an initial dose and a subsequent “booster” dose after a few weeks.

Playing:
Look at this:

Your phone may be a powerful tool to help you stop …

1:34

Moderna and Pfizer will apply for an emergency permit from the FDA this month. Pfizer expects to produce up to 50 million vaccines in 2020 and 1.3 billion in 2021 if approved. Moderna plans to ship 20 million vaccines in 2020 and an additional 500 to 1 billion vaccines in 2021 if approved. There are over 330 million people in the United States alone. Not everyone can be vaccinated Immediately-The first dose to reach the market will probably go to healthcare professionals, then to essential workers, people with underlying illnesses, and the elderly. Oxford’s next step is to submit the collected data to regulators around the world for product approval.

Pfizer, Moderna and Oxford are just the tip of the iceberg. Current, 67 Coronavirus vaccine At various stages of the clinical trial, you are almost ready to apply for approval.Most experts believe there are a few more Ready to distribute by early 2021However, life may not begin to return to normal until 2022.

Here’s the news of the major coronavirus vaccines and where the most promising candidates stand. This article is updated frequently and is for general overview purposes and is not a source of medical advice. If you’re looking for more information about coronavirus testing, Here’s how to find a test site near you..

Important COVID-19 Vaccine News

Development of COVID-19 vaccine is very fast

Several acceleration efforts are currently underway. Operation White House Warp SpeedAims to speed up vaccine development through regulatory bureaucratic formalism and enable vaccines to be distributed as soon as they are approved by the FDA.So far, the U.S. government has Pledge over $ 10 billion To several vaccine makers to ensure a total of 800 million vaccine doses.

Vaccines are usually about 10 to 15 years to develop Approve through 4 phases including Human clinical trial.. However, Operation Warp Speed ​​allows approved vaccine projects to send data to the FDA in small increments instead of sending all the data from the four-stage trial at once.

Meanwhile, the program financially supports efforts to start production doses while clinical trials are still in progress. This means that if these vaccines are approved, there is already a store of doses ready for distribution nationwide.

Other promising coronavirus vaccines around the world

Let’s take a quick look at some of the leading candidates other than Pfizer and Moderna in the race to find the COVID-19 vaccine. This includes where the vaccine is being developed, where it is being tested, and when scientists think it is ready for dissemination. Distribute if you know.

Playing:
Look at this:

Vaccines, antibody tests, treatments: science …

6:02

Oxford University / AstraZeneca (UK): AstraZeneca has started testing 100,000 volunteers in at least 3 countries..Dr. Sara Gilbert, a senior researcher, initially said that AstraZeneca Aiming for release in the fall of 2020 And while it may be optimistic at this point after the trial was suspended to investigate the participant’s illness, it does not appear to be significantly delayed. Currently, it has an average effect of 70%.

Shinobak (China): Currently testing vaccines at about 10,000 volunteers in China And About 9,000 in Brazil Is set to start testing at about 1,900 subjects in Indonesia Soon. Honesti Basyir, president of Sinovac’s Indonesian partner BioFarma, said the vaccine Ready by early 2021..

Shinofarm (China): Currently testing 15,000 volunteers in the Middle East The trial expects state-owned enterprises to last three to six months.early Results suggest that the drug is safe And at least somewhat effective. Sinopharm recently Second facility to manufacture vaccines, Double its capacity to about 200 million times a year.

CanSino Biologics (China): For a large-scale start Human experimentation this summer, CanSino vaccine already Approved by the Chinese army.. The vaccine is based on a modified common cold virus. Some experts warn It may be less effective than other vaccine efforts.

How many vaccines does the United States need?

You probably won’t know until next year, but Fauci suggested that we might need it. Several different vaccines Created and distributed by various labs to put an end to the pandemic. A paper published in the journal Science on May 11th..He also said he foresaw different Vaccines are given to different patient populations.. For example, one vaccine is for the elderly or other high-risk patients, the other is for healthy adults, and the other is for children.

What if people don’t trust the vaccine?

Obtaining FDA approval for one or more vaccines through clinical trials is only the first step in your journey. The next is to persuade people to take it. Sixty-three percent of adults in the United States have expressed safety concerns about the coronavirus vaccine. Harris paul Since October 19, 40% of respondents have been developing Too fast.Some people reportedly Worried about possible side effects..

When scientists reach what they call “”, life in the United States begins to return to normal.Herd immunity, “This means that at least 60% to 70% of the population is immune to the coronavirus. As long as a sufficient number of people are vaccinated to reach that level, it doesn’t matter if a few people oppose or reject it. Vaccine for other reasons. For example, if you are not in good health to be vaccinated.

What should I do until the coronavirus vaccine is approved?

Coronavirus is a large class of viruses, So far there is no vaccine For any of them. Although there are promising early results, there is no guarantee that the vaccine will be ready by 2021. Statistically, only about 6% of vaccine candidates are on the market. According to a Reuters report From April.But health officials are very optimistic that Pfizer vaccines and others like it Can end the coronavirus pandemic..

Whether the COVID-19 vaccine is effective in blocking the spread of the coronavirus depends largely on how our body builds immunity to the disease.This is what we ever know about if you can Obtain COVID-19 multiple times..Testing is also the key to slowing the spread of the coronavirus-learn about devices that can produce results Less than 90 minutes here..Finally, read about all these issues and how more will affect Joseph in the US presidential election. Biden’s plan to fight COVID-19..

The information contained in this article is for educational and informative purposes only and is not intended to provide health or medical advice. Always consult your doctor or other qualified healthcare provider if you have any questions about your medical condition or health goals.